Journal of Vascular Surgery
Volume 33, Issue 4 , Pages 847-853 , April 2001

Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein

Received 10 April 2000 ,Accepted 14 September 2000.

References 

  1. Resch KL, Ernst E. Fibrinogen and viscosity: risk factors for cardiovascular events. Compr Ther. 1994;20:170–173
  2. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation. 1995;92:31–38
  3. Tschopl M, Tsakiris DA, Marbet GA, Labs KH, Jager K. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol. 1997;17:3208–3214
  4. Bosmans JM, Kockx MM, Vrints CJ, Bult H, DeMeyer GRY, Herman AG. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. Arterioscler Thromb Vasc Biol. 1997;17:634–645
  5. Wiseman S, Kenchington G, Dain R, Marshall CE, McCollum CN, Greenhalgh RM, et al.  Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ. 1989;299:643–646
  6. Hicks RC, Ellis M, Mir H, Higman DJ, Nott D, Greenhalgh RM, et al.  The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg. 1995;9:415–420
  7. Weiss HJ, Turitto VT, Baumgartner HR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium: studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest. 1986;78:1072–1082
  8. Tijburg PN, Ijsseldijk MJ, Sixma JJ, De Groot PG. Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen: high shear rates induce decreased fibrin deposition and appearance of fibrin monomers. Arterioscler Thromb. 1991;11:211–220
  9. Mailhac A, Badimon JJ, Fallon JT, Fernandez O, Meyer B, Chesebro JH, et al.  Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis: relative contribution of fibrin(ogen) and platelets. Circulation. 1994;90:988–996
  10. Gray AJ, Bishop JE, Reeves JT, Laurent GJ. A-alpha and B-beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci. 1993;104:409–413
  11. Gray AJ, Pyong WP, Broekelmann TJ, Laurent GJ, Reeves JT, Stenmark KR, et al.  The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J Biol Chem. 1995;270:26602–26606
  12. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood. 1995;86:1802–1810
  13. Levesque J, Hatzfeld A, Hudry C, Wilner GD, Hatzfeld J. Evidence for two functionally different fibrinogen receptors on hemopoietic cells. J Cell Physiol. 1987;132:303–310
  14. Robson SC, Saunders R, Purves LR, De Jager C, Corrigall A, Kirsch RE. Fibrin and fibrino-gen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood. 1993;81:3006–3014
  15. Gardiner EE, D'Souza SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem. 1997;272:15474–15480
  16. Gardiner EE, D'Souza SE. Sequences within fribronogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis. J Biol Chem. 1999;274:11930–11936
  17. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863–868
  18. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens. 1997;6:88–105
  19. Schor SL. Cell proliferation and migration on collagen substrata in vitro. J Cell Sci. 1980;41:159–175
  20. Martin GR, Sank AC. Extracellular matrices, cells, and growth factors. In:  Sporn MB,  Roberts AB editor. Peptide growth factors and their receptors II. Berlin: Springer-Verlag; 1990;p. 463–477
  21. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069–1078
  22. Indolfi C, Avvedimento EV, Di LE, Esposito G, Rapacciuolo A, Giuliano P, et al.  Activation of cAMP-PKA signaling in vivo inhibits smooth muscle proliferation induced by vascular injury. Nat Med. 1997;3:775–779
  23. Campbell GR, Campbell JH. Phenotypic modulation of smooth muscle cells in primary culture. In: 1st ed.  Campbell GR,  Campbell JH editor. Vascular smooth muscle in culture. Boca Raton: CRC; 1987;p. 39–55
  24. Weitz JI, Leslie B. Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin. J Clin Invest. 1990;86:203–212
  25. Ishida T, Tanaka K. Effects of fibrinogen and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 1982;44:161–174
  26. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 1998;273:7554–7559
  27. Singh TM, Kadowaki MH, Glagov S, Zarins CK. Role of fibrinopeptide-B in early atherosclerotic lesion formation. Am J Surg. 1990;160:156–159
  28. Kadowaki MH, Singh TM, Zarins CK, Glagov S, Meredith SC. The effect of hypercholesterolemia on early atherosclerotic lesions initiated by fibrinopeptide B. J Surg Res. 1991;51:524–528

 Competition of interest: nil.

☆☆ Supported by The British Vascular Foundation, The Royal College of Surgeons, Charing Cross and Westminster Medical School Special Trustees, and The Camelia Botnar Research Foundation.

 Reprint requests: Prof J. T. Powell, University Hospitals of Coventry & Warwickshire, Clifford Bridge Road, Coventry CV2 2DX (e-mail: Janet.Powell@wh-tr.wmids.nhs.wk ).

PII: S0741-5214(01)78806-4

doi: 10.1067/mva.2001.111984

Journal of Vascular Surgery
Volume 33, Issue 4 , Pages 847-853 , April 2001